Natco Pharma Ltd

Board Meeting Intimation for To Consider The Unaudited Financial Results For The Quarter Ended 31St

04:04 PM, 31st Jan 2023

NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve the unaudited financial results for the quarter ended 31st December 2022 and to consider the third interim dividend if any

Natco Pharma Ltd

Board Meeting Intimation for To Consider The Unaudited Financial Results For The Quarter Ended 31St

More Natco Pharma Ltd Announcements